BioHarvest Sciences Inc. Files 6-K Report

Ticker: BHST · Form: 6-K · Filed: Feb 14, 2025

Sentiment: neutral

Topics: sec-filing, 6-k, foreign-private-issuer

Related Tickers: BHSC

TL;DR

BioHarvest Sciences (BHSC) filed a 6-K, standard reporting for foreign issuers.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on February 14, 2025, reporting as a foreign private issuer. The company, previously known as CANNA-V-CELL SCIENCES INC. and Midnight Star Ventures Corp., is incorporated in A1 and has its principal executive offices in Vancouver, British Columbia, Canada.

Why It Matters

This filing indicates BioHarvest Sciences Inc. is providing updated information to the SEC as a foreign private issuer, which is standard for ongoing compliance.

Risk Assessment

Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material financial information or strategic changes.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.

What were BioHarvest Sciences Inc.'s previous names?

BioHarvest Sciences Inc. was formerly known as CANNA-V-CELL SCIENCES INC. and Midnight Star Ventures Corp.

Where are BioHarvest Sciences Inc.'s principal executive offices located?

The principal executive offices of BioHarvest Sciences Inc. are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

What is the SIC code for BioHarvest Sciences Inc.?

The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Does BioHarvest Sciences Inc. file under Form 20-F or Form 40-F?

BioHarvest Sciences Inc. indicates it files annual reports under cover of Form 20-F.

Filing Stats: 205 words · 1 min read · ~1 pages · Grade level 18.1 · Accepted 2025-02-14 13:46:01

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: February 14, 2025 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary

View on Read The Filing